These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 9864827)

  • 21. Comparative studies on neutralisation of primary HIV-1 isolates by human sera and rabbit anti-V3 peptide sera.
    Lawoko AL; Johansson B; Hjalmarsson S; Christensson B; Ljungberg B; Al-Khalili L; Sjölund M; Pipkorn R; Fenyö EM; Blomberg J
    J Med Virol; 1999 Oct; 59(2):169-79. PubMed ID: 10459152
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distribution of linear antigenic epitopes on GP120 encoded in sibling clones of novel New York HIV-1 subtype B isolates.
    Riley JP; Pestano GA; Harewood K; Alfred LJ; Guyden J; Boto WM
    Cell Mol Biol (Noisy-le-grand); 1995; 41 Suppl 1():S83-91. PubMed ID: 8574151
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HIV type 1 subtype E-infected patients with broadened, dual (B/E) V3 loop serology have increased cross-neutralizing antibodies.
    Polonis VR; De Souza MS; Chanbancherd P; Chantakulkij S; Jugsudee A; Loomis-Price LD; Vancott TC; Garner R; Markowitz LE; Brown AE; Birx DL
    AIDS Res Hum Retroviruses; 2001 Jan; 17(1):69-79. PubMed ID: 11177385
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HIV-1 diversity in heterosexual population in Slovakia, Ukraine and the Czech Republic.
    Mayer V; Apetrei C; Habekova M; Tchentsova N; Bruckova M; Klaskala W; Baum MK; Brun-Vézinet F; Simon F
    AIDS; 1998 Jun; 12(9):1106-8. PubMed ID: 9662210
    [No Abstract]   [Full Text] [Related]  

  • 25. Differential role of V3-specific antibodies in neutralization assays involving primary and laboratory-adapted isolates of HIV type 1.
    Vancott TC; Polonis VR; Loomis LD; Michael NL; Nara PL; Birx DL
    AIDS Res Hum Retroviruses; 1995 Nov; 11(11):1379-91. PubMed ID: 8573396
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HIV type 1 V3 serotyping of Tanzanian samples: probable reasons for mismatching with genetic subtyping.
    Hoelscher M; Hanker S; Barin F; Cheingsong-Popov R; Dietrich U; Jordan-Harder B; Olaleye D; Nägele E; Markuzzi A; Mwakagile D; Minja F; Weber J; Gürtler L; Von Sonnenburg F
    AIDS Res Hum Retroviruses; 1998 Jan; 14(2):139-49. PubMed ID: 9462924
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The relationship between HIV type 1 disease progression and V3 serotype in a rural Ugandan cohort.
    Senkaali D; Muwonge R; Morgan D; Yirrell D; Whitworth J; Kaleebu P
    AIDS Res Hum Retroviruses; 2004 Sep; 20(9):932-7. PubMed ID: 15585080
    [TBL] [Abstract][Full Text] [Related]  

  • 28. V3 serotyping of HIV-1 infection: correlation with genotyping and limitations.
    Plantier JC; Damond F; Lasky M; Sankalé JL; Apetrei C; Peeters M; Buzelay L; M'Boup S; Kanki P; Delaporte E; Simon F; Barin F
    J Acquir Immune Defic Syndr Hum Retrovirol; 1999 Apr; 20(5):432-41. PubMed ID: 10225224
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HIV disease progression and V3 serotypes in Brazil: is B different from B-Br?
    Santoro-Lopes G; Harrison LH; Tavares MD; Xexéo A; Dos Santos AC; Schechter M
    AIDS Res Hum Retroviruses; 2000 Jul; 16(10):953-8. PubMed ID: 10890356
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High prevalence of antibodies to the gp120 V3 region principal neutralizing determinant of HIV-1MN in sera from Africa and the Americas.
    Carrow EW; Vujcic LK; Glass WL; Seamon KB; Rastogi SC; Hendry RM; Boulos R; Nzila N; Quinnan GV
    AIDS Res Hum Retroviruses; 1991 Oct; 7(10):831-8. PubMed ID: 1720630
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of different V3 peptides in an enzyme immunoassay for specific HIV type 1 group O antibody detection.
    Ondoa P; Willems B; Fransen K; Nkengasong J; Janssens W; Heyndrickx L; Zekeng L; Ndumbe P; Simon F; Saragosti S; Gürtler L; Peeters M; Korber B; Goudsmit J; van der Groen G
    AIDS Res Hum Retroviruses; 1998 Jul; 14(11):963-72. PubMed ID: 9686642
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of neutralizing and enhancing antibodies to human immunodeficiency virus type 1 primary isolates in plasma of individuals infected with env Genetic subtype B and E viruses in Thailand.
    Auewarakul P; Louisirirotchanakul S; Sutthent R; Taechowisan T; Kanoksinsombat C; Wasi C
    Viral Immunol; 1996; 9(3):175-85. PubMed ID: 8890476
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rapid grouping of HIV-1 infection in subtypes A to E by V3 peptide serotyping and its relation to sequence analysis.
    Sherefa K; Sönnerborg A; Steinbergs J; Sällberg M
    Biochem Biophys Res Commun; 1994 Dec; 205(3):1658-64. PubMed ID: 7811250
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antigenic variation and serotyping of HIV type 1 from four World Health Organization-sponsored HIV vaccine sites. WHO Network for HIV Isolation and Characterization.
    Pau CP; Kai M; Holloman-Candal DL; Luo CC; Kalish ML; Schochetman G; Byers B; George JR
    AIDS Res Hum Retroviruses; 1994 Nov; 10(11):1369-77. PubMed ID: 7888190
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic similarity of HIV type 1 subtype E in a recent outbreak among injecting drug users in northern Vietnam to strains in Guangxi Province of southern China.
    Kato K; Shiino T; Kusagawa S; Sato H; Nohtomi K; Shibamura K; Nguyen TH; Pham KC; Truong XL; Mai HA; Hoang TL; Bunyaraksyotin G; Fukushima Y; Honda M; Wasi C; Yamazaki S; Nagai Y; Takebe Y
    AIDS Res Hum Retroviruses; 1999 Sep; 15(13):1157-68. PubMed ID: 10480629
    [TBL] [Abstract][Full Text] [Related]  

  • 36. V3 peptide enzyme immunoassay for serotyping HIV-1 infected pregnant Thais.
    Taechowisan T; Sutthent R; Louisirirotchanakul S; Puthavathana P; Wasi C
    Asian Pac J Allergy Immunol; 1996 Dec; 14(2):121-3. PubMed ID: 9177826
    [TBL] [Abstract][Full Text] [Related]  

  • 37. First report of CRF03_AB recombinant HIV type 1 in injecting drug users in Ukraine.
    Naganawa S; Sato S; Nossik D; Takahashi K; Hara T; Tochikubo O; Kitamura K; Honda M; Nakasone T
    AIDS Res Hum Retroviruses; 2002 Oct; 18(15):1145-9. PubMed ID: 12402952
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Temporal trends in the HIV-1 epidemic in Russia: predominance of subtype A.
    Bobkov AF; Kazennova EV; Selimova LM; Khanina TA; Ryabov GS; Bobkova MR; Sukhanova AL; Kravchenko AV; Ladnaya NN; Weber JN; Pokrovsky VV
    J Med Virol; 2004 Oct; 74(2):191-6. PubMed ID: 15332265
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diversity of antibody binding to V3 peptides representing consensus sequences of HIV type 1 genotypes A to E: an approach for HIV type 1 serological subtyping.
    Barin F; Lahbabi Y; Buzelay L; Lejeune B; Baillou-Beaufils A; Denis F; Mathiot C; M'Boup S; Vithayasai V; Dietrich U; Goudeau A
    AIDS Res Hum Retroviruses; 1996 Sep; 12(13):1279-89. PubMed ID: 8870850
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dynamics of the HIV-1 variability in adults from Bucharest, 1992-1998.
    Chiţu V; Diaconu CC; Veliceasa D; Ruţă S; Grancea C; Târdei G; Cernescu CE
    Rom J Virol; 1999; 50(1-4):43-51. PubMed ID: 11601379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.